Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

Journal:

The Lancet

Published:

2026-05-02

DOI:

10.1016/s0140-6736(26)00305-3

Affiliations:

12

Authors:

17

Go to article

Institutions	Authors	Share
Copenhagen University Hospital (CUH), Denmark	6.000000	0.35
University of Copenhagen (UCPH), Denmark	5.500000	0.32
Rigshospitalet, Denmark	1.000000	0.06
Odense University Hospital (OUH), Denmark	1.000000	0.06
NIH National Institute on Drug Abuse (NIDA), United States of America (USA)	1.000000	0.06
Yale University, United States of America (USA)	1.000000	0.06
NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA), United States of America (USA)	1.000000	0.06
Steno Diabetes Center Copenhagen (SDCC), Denmark	0.500000	0.03

Interested in Health Services and Systems?